Nomenclature of Systemic Vasculitides

Authors

  • J. Charles Jennette MD,

    Corresponding author
    1. Mount Sinai School of Medicine and Barnert Hospital
    • Department of Pathology, Campus Box #7525, School of Medicine, University of North Carolina, Chapel Hill, NC 27599
    Search for more papers by this author
  • Ronald J. Falk MD,

    1. Mount Sinai School of Medicine and Barnert Hospital
    Search for more papers by this author
  • Konrad Andrassy MD,

    1. Mount Sinai School of Medicine and Barnert Hospital
    Search for more papers by this author
  • Paul A. Bacon MD, FRCP,

    1. Mount Sinai School of Medicine and Barnert Hospital
    Search for more papers by this author
  • Jacob Churg MD,

    1. Mount Sinai School of Medicine and Barnert Hospital
    2. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Wolfgang L. Gross MD,

    1. Medical University of Lübeck and the Rheumatic Disease Clinic of Bad Bramstedt
    2. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • E. Christiaan Hagen MD,

    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Gary S. Hoffman MD,

    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Gene G. Hunder MD,

    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Cees G. M. Kallenberg MD,

    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Robert T. Mccluskey MD,

    1. Royal Post-graduate Medical School
    2. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • R. Alberto Sinico MD,

    1. Mount Sinai School of Medicine and Barnert Hospital
    2. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Andrew J. Rees MSc, FRCP,

    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Leendert A. Van Es MD, PhD,

    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • RÜDiger Waldherr MD,

    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author
  • Allan Wiik MD, PhD

    Statens Seruminstitut
    1. University of North Carolina, Chapel Hill, North Carolina; the University of Heidelberg, Heidelberg, Germany; The University of Birmingham, Birmingham, England; the Mount Sinai School of Medicine, New York, New York; Barnert Hospital, Paterson New Jersey; Medical University of Lübeck and the Rheumatic Disease Clinic of Bramstedt, Bad Bramstedt, Germany; the University Hospital of Leiden, Leiden, the Netherlands; The Cleveland Clinic Foundation, Cleveland, OH; The Mayo Clinic, Rochester, MN; University Hospital Groningen, Groningen, The Netherlands; Harvard Medical School, Boston, Massachusetts; the Royal Postgraduate Medical School, London, England; the Ospedale S. Carlo Borromeo-Milano, Milan, Italy; and Statens Seruminstitut, Copenhagen, Denmark.
    Search for more papers by this author

Ancillary